Putri DA, Setiawan D, Yamsun M. Cost-Utility Analysis Addition of Bevacizumab to Standard Chemotherapy in KRAS-mutation Colorectal Cancer. Pharm. : j. farm. Indones. [Internet]. 2025 Aug. 19 [cited 2026 Jun. 6];22(1):6-11. Available from: http://jurnalnasional.ump.ac.id/index.php/PHARMACY/article/view/24298